Cite
HARVARD Citation
Yalon, M. et al. (n.d.). A feasibility and efficacy study of rapamycin and erlotinib for recurrent pediatric low‐grade glioma (LGG)1. Pediatric blood & cancer. 60 (1), pp. 71-76. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yalon, M. et al. (n.d.). A feasibility and efficacy study of rapamycin and erlotinib for recurrent pediatric low‐grade glioma (LGG)1. Pediatric blood & cancer. 60 (1), pp. 71-76. [Online].